• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带BRCA1/2基因突变风险的阿什肯纳兹犹太个体患乳腺癌的主观和客观风险。

Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations.

作者信息

Kelly Kimberly, Leventhal Howard, Marvin Monica, Toppmeyer Deborah, Much Judith, Dermody James, Baran Jill, Schwalb Marvin

机构信息

Human Cancer Genetics Program, Ohio State University, Columbus, OH 43221, USA.

出版信息

Genet Test. 2004 Summer;8(2):139-47. doi: 10.1089/gte.2004.8.139.

DOI:10.1089/gte.2004.8.139
PMID:15345111
Abstract

The aims of the study were to (1) examine the differences between subjective and objective estimates of the risk of breast cancer in those being tested for BRCA1/2 mutations, (2) explore new ways to conceptualize risk, and (3) examine the change in subjective risk of developing breast cancer throughout the process of genetic counseling and testing. Participants were 86 Ashkenazi Jewish women with a family or personal history indicating risk for BRCA1/2 mutations. Surveys to assess subjective risk of breast cancer (percentage risk, projected age of onset, and survival time) were administered before counseling, after counseling, and after receipt of test results. Subjective percentage risk of breast cancer was compared to estimated objective risk to determine accuracy. Those with no personal history of cancer receiving positive results became more accurate from post-counseling to post-result. Those receiving positive results increased their estimate of their percentage risk, and those receiving uninformative negative results decreased their estimate of their percentage risk from post-counseling to post-result. Those without a personal history of cancer decreased in perceived risk from post-counseling to post-result. No change in projected age of onset of breast cancer or survival time with breast cancer was seen from pre- to post-counseling or from post-counseling to post-result, and no change in accuracy or in percentage risk of breast cancer was seen from pre- to post-counseling. Individuals use information from genetic counseling to form estimates of percentage risk following receipt of test results; however, projected age of onset and survival time with breast cancer, areas not targeted by genetic counseling that may be more closely linked to health behavior, do not change.

摘要

本研究的目的是

(1)检查在接受BRCA1/2突变检测的人群中,乳腺癌风险主观估计与客观估计之间的差异;(2)探索概念化风险的新方法;(3)检查在整个遗传咨询和检测过程中,患乳腺癌主观风险的变化。研究对象为86名有家族或个人病史表明存在BRCA1/2突变风险的阿什肯纳兹犹太女性。在咨询前、咨询后以及收到检测结果后,进行了评估乳腺癌主观风险(风险百分比、预计发病年龄和生存时间)的调查。将乳腺癌主观风险百分比与估计的客观风险进行比较,以确定准确性。没有个人癌症病史且检测结果为阳性的人,从咨询后到收到结果后,其估计变得更加准确。检测结果为阳性的人提高了对自身风险百分比的估计,而检测结果为无信息的阴性的人从咨询后到收到结果后降低了对自身风险百分比的估计。没有个人癌症病史的人从咨询后到收到结果后,感知到的风险降低。从咨询前到咨询后,以及从咨询后到收到结果后,未观察到乳腺癌预计发病年龄或乳腺癌生存时间的变化,从咨询前到咨询后,也未观察到乳腺癌准确性或风险百分比的变化。个体在收到检测结果后,利用遗传咨询中的信息来形成对风险百分比的估计;然而,乳腺癌预计发病年龄和生存时间,这些并非遗传咨询所针对的、可能与健康行为联系更紧密的方面,并未改变。

相似文献

1
Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations.携带BRCA1/2基因突变风险的阿什肯纳兹犹太个体患乳腺癌的主观和客观风险。
Genet Test. 2004 Summer;8(2):139-47. doi: 10.1089/gte.2004.8.139.
2
Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.在检测BRCA1/2突变的阿什肯纳兹犹太女性中,卵巢癌的主观和客观风险
Patient Educ Couns. 2008 Jan;70(1):135-42. doi: 10.1016/j.pec.2007.09.007. Epub 2007 Nov 7.
3
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.携带BRCA1和BRCA2突变的阿什肯纳兹犹太女性患卵巢癌的风险。
Clin Cancer Res. 2002 Dec;8(12):3776-81.
4
Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.阿什肯纳兹犹太裔患者中BRCA1和BRCA2非始祖突变的发生率。
Breast Cancer Res Treat. 2015 Jan;149(1):223-7. doi: 10.1007/s10549-014-3218-x. Epub 2014 Dec 6.
5
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.在德系犹太人个体中,BRCA2基因6174delT突变的携带频率约为1%。
Nat Genet. 1996 Oct;14(2):188-90. doi: 10.1038/ng1096-188.
6
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?以色列 BRCA1/BRCA2 突变携带者家族中表型复制型乳腺癌的发生率:非携带者的风险是否增加?
Breast Cancer Res Treat. 2012 Apr;132(2):669-73. doi: 10.1007/s10549-011-1886-3. Epub 2011 Nov 24.
7
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.在阿什肯纳兹族乳腺癌和卵巢癌家族中未发现基因组 BRCA1 和 BRCA2 重排。
Breast Cancer Res Treat. 2010 Sep;123(2):581-5. doi: 10.1007/s10549-010-0818-y. Epub 2010 Mar 11.
8
Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.阿什肯纳兹犹太个体在接受BRCA1/2突变咨询时的癌症遗传学知识、信念及结果接收情况
Cancer Control. 2004 Jul-Aug;11(4):236-44. doi: 10.1177/107327480401100405.
9
Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation.犹太裔 BRCA1 和 BRCA2 基因突变携带者的癌症风险:口服避孕药使用和突变来源的影响。
Breast Cancer Res Treat. 2011 Sep;129(2):557-63. doi: 10.1007/s10549-011-1509-z. Epub 2011 Apr 16.
10
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.携带BRCA1和BRCA2基因突变的阿什肯纳兹犹太人群患乳腺癌的终生风险。
Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):467-73.

引用本文的文献

1
Network Modeling of Complex Time-Dependent Changes in Patient Adherence to Adjuvant Endocrine Treatment in ER+ Breast Cancer.雌激素受体阳性乳腺癌患者辅助内分泌治疗依从性复杂时间依赖性变化的网络建模
Front Psychol. 2022 Jul 12;13:856813. doi: 10.3389/fpsyg.2022.856813. eCollection 2022.
2
What does risk of future cancer mean to breast cancer patients?乳腺癌患者的“未来癌症风险”意味着什么?
Breast Cancer Res Treat. 2019 Jun;175(3):579-584. doi: 10.1007/s10549-019-05182-3. Epub 2019 Mar 6.
3
Genetic counseling content: How does it impact health behavior?
遗传咨询内容:它如何影响健康行为?
J Behav Med. 2015 Oct;38(5):766-76. doi: 10.1007/s10865-014-9613-2. Epub 2014 Dec 23.
4
Linking genetic counseling content to short-term outcomes in individuals at elevated breast cancer risk.将遗传咨询内容与乳腺癌高风险个体的短期结果相联系。
J Genet Couns. 2014 Oct;23(5):838-48. doi: 10.1007/s10897-014-9705-8. Epub 2014 Mar 28.
5
Closing the loop: an interactive action-research conference format for delivering updated medical information while eliciting Latina patient/family experiences and psychosocial needs post-genetic cancer risk assessment.闭环:一种互动式行动研究会议形式,用于提供更新的医学信息,同时在遗传癌症风险评估后征集拉丁裔患者/家庭的经验和心理社会需求。
Fam Cancer. 2012 Sep;11(3):449-58. doi: 10.1007/s10689-012-9535-5.
6
Cancer recurrence worry, risk perception, and informational-coping styles among Appalachian cancer survivors.阿巴拉契亚癌症幸存者的癌症复发担忧、风险感知和信息应对方式。
J Psychosoc Oncol. 2011;29(1):1-18. doi: 10.1080/07347332.2011.534014.
7
Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers.遗传咨询中遗传性乳腺癌和/或卵巢癌的主观风险与客观风险。
J Exp Clin Cancer Res. 2009 Dec 21;28(1):157. doi: 10.1186/1756-9966-28-157.
8
Health behaviors among Ashkenazi Jewish individuals receiving counseling for BRCA1 and BRCA2 mutations.接受 BRCA1 和 BRCA2 突变咨询的阿什肯纳兹犹太个体的健康行为。
Fam Cancer. 2009;8(3):241-50. doi: 10.1007/s10689-009-9235-y. Epub 2009 Jan 28.
9
Perceived risk of breast cancer among Latinas attending community clinics: risk comprehension and relationship with mammography adherence.在社区诊所就诊的拉丁裔女性中对乳腺癌的感知风险:风险认知及其与乳房X光检查依从性的关系。
Cancer Causes Control. 2008 Dec;19(10):1373-82. doi: 10.1007/s10552-008-9209-7. Epub 2008 Aug 15.
10
Cancer family history reporting: impact of method and psychosocial factors.癌症家族史报告:方法及社会心理因素的影响
J Genet Couns. 2007 Jun;16(3):373-82. doi: 10.1007/s10897-006-9076-x. Epub 2007 Feb 23.